Medoctor, Inc. Receives US Patent

NAPA, Calif.--(BUSINESS WIRE)--Medoctor, Inc., received a US Patent entitled: “System
and Method for Determining the Probable Existence of Disease."
Medoctor’s operating technology is an Internet
health assessment and personal record keeping system. Medoctor
determines the probability of disease, thereby reducing medical errors
and wasteful use of healthcare resources.

“System
and Method for Determining the Probable Existence of Disease.”

The Medoctor system utilizes mathematical algorithms like those used in
the hit TV show “Numbers”.
While the TV show solves crime mysteries, Medoctor solves medical
mysteries, to the satisfaction of the United States Patent Office and
the World Health Organization (WHO).

Developed by a team of 25 medical researchers in Santa Rosa, California,
Medoctor performs a differential diagnosis (DDX) of over 830 diseases
and conditions in five languages - English, Spanish, French, German and
Italian, on its website www.medoctor.com.
Each Medoctor user creates a personal electronic health record.

The American Telemedicine Association’s paper, “Telemedicine
and Federal Policy”, promotes the use of “telemedicine
triage” stations in community centers and
pharmacies. Medoctor can be deployed in clinics, like those being
developed by Wal-Mart; CVS, Walgreen and Rite-Aid pharmacies, to provide
for the millions without health insurance.

A study by Sonoma County, California found that 64% of emergency room
visits can be handled in less-costly, non-emergency settings. Hospitals
absorb unnecessary ER costs in their community service budgets. Medoctor’s
triage system could save hospitals and government agencies billions of
dollars annually.

Governments have long searched for an affordable health record-keeping
solution. Medoctor combines a diagnostic tool with a personal health
record, helping individuals, healthcare payers and providers alike. The
United Nations’ International
Telecommunication Union (ITU) funded a pilot project of Medoctor in
rural Africa.

Medoctor will develop strategic alliances with pharmaceutical companies
to reduce development costs of new drugs and speed FDA approval. Medoctor’s
databases provide efficient means of collecting data. The totality of
the data collected will be valuable in biotech research. A license
agreement is being negotiated with a major wireless company to adapt
Medoctor for worldwide use on cell phones.

There are some 47,000,000+ people in the USA without health insurance.
Medoctor is an affordable solution for this unacceptable problem.
Medoctor provides a basic diagnosis to allow everyone an opportunity to
know what ails them, as well as, to record all data as an electronic
health record for physicians.